Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 23Genitourinary 16Gastrointestinal 16Other hematologic neoplasm 14Lymphoid 11Myeloid 5Dermatologic 5CNS 5Gynecologic 4Classical hematology 3Other 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other neoplasm 1Endocrine 1

Conditions

Vitamin D Deficiency 1Multiple Myeloma 1

Interventions

Dexamethasone 479Lenalidomide 297Cyclophosphamide 271Bortezomib 267Melphalan 212Calcium Dobesilate 189fludarabine phosphate 121daratumumab 121Peripheral Blood Stem Cell Transplantation 101fludarabine 99carfilzomib 98Thalidomide 94pomalidomide 92Filgrastim 92Whole-Body Irradiation 88Mycophenolic Acid 88Busulfan 80Tacrolimus 75Granulocyte Colony-Stimulating Factor 72dexamethasone acetate 65ixazomib 62Cyclosporine 59dexamethasone 21-phosphate 56Antilymphocyte Serum 51auricularum 50isatuximab 44Radiotherapy 41Etoposide 40Stem Cell Transplantation 39Methotrexate 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholecalciferol × Plasma cell × Clear all
NCT05846880 2025-04-08

VitD3 Supplementation in Patients With Multiple Myeloma

Augusta University

Phase EARLY_PHASE1 Recruiting
100 enrolled
Plasma cell

Multiple Myeloma, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡